Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
3.750
-0.190 (-4.82%)
At close: Feb 4, 2026, 4:00 PM EST
3.750
0.00 (0.00%)
After-hours: Feb 4, 2026, 4:00 PM EST
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $110.42 million as of February 4, 2026.
Market Cap
110.42M
Enterprise Value
104.75M
1-Year Change
n/a
Ranking
Category
Stock Price
3.75
Market Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has decreased from $196.16M to $110.42M, a decrease of -43.71%. That is a compound annual growth rate of -83.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 116.01M | - |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 113.69M |
| Genelux | 113.37M |
| Inovio Pharmaceuticals | 113.02M |
| Coya Therapeutics | 111.37M |
| MacroGenics | 108.80M |
| ALX Oncology Holdings | 107.62M |
| Actuate Therapeutics | 107.38M |
| Cardiff Oncology | 105.76M |